PhaseV Revenue

Biotechnology Research • Boston, Massachusetts, United States • 21-50 Employees

PhaseV revenue & valuation

Annual revenue	$32,000,000
Revenue per employee	$696,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$102,400,000
Total funding	$65,000,000

Key Contacts at PhaseV

Cheryl Fitzer-Attas

Medical Director

Raviv Pryluk

Ceo And Co-Founder

Elad Berkman

Cto & Co-Founder

Brad Carlin

Senior Director

Yael Hadad

Associate Director Of Partnerships

Keren Peri-Hanania

Medical Director

Company overview

Headquarters	200 Portland St, Boston, Massachusetts 02114, US
Website	phasevtrials.com
NAICS	541714
Employees	21-50
Socials

PhaseV Email Formats

PhaseV uses 3 email formats. The most common is {first name} (e.g., john@phasevtrials.com), used 63.4% of the time.

Format	Example	Percentage
{first name}	john@phasevtrials.com	63.4%
{first initial}	j@phasevtrials.com	29.3%
{first initial}.{last name}	j.doe@phasevtrials.com	7.3%

About PhaseV

PhaseV is a Boston-based technology company transforming clinical development with an enterprise-ready AI/ML platform that accelerates decisions, de-risks trials, and drives portfolio efficiency. Its Trial Optimizer designs smarter studies, reducing costs by up to 50%, lowering enrollment needs by 40%, shortening timelines by 40%, and boosting probability of success by 30%+. The ClinOps Optimizer enhances site selection by integrating patient-level insights with real-time dashboards to track performance. The Lifecycle Management module combines causal evidence, development complexity, and market value to inform portfolio decisions. Together, these solutions enable sponsors and CROs to optimize every stage of development.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Head

Employees by Department

PhaseV has 29 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore PhaseV's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-11-24	3	$15,000,000
2025-06-13	4	$50,000,000

Funding Insights

$65,000,000

Total funding amount

$50,000,000

Most recent funding amount

Number of funding rounds

PhaseV Tech Stack

Discover the technologies and tools that power PhaseV's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Adobe Fonts

Font scripts

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Nginx

Reverse proxies

Slick

JavaScript libraries

Contact Form 7

Form builders

PHP

Programming languages

Open Graph

Miscellaneous

WordPress

Blogs

jQuery Migrate

JavaScript libraries

Google Analytics

Analytics

Frequently asked questions

PhaseV is located in Boston, Massachusetts, US.

PhaseV generates an estimated annual revenue of $32,000,000. This revenue figure reflects the company's market position and business performance in its industry.

PhaseV has an estimated valuation of $102,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

PhaseV has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

PhaseV has raised a total of $65,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at PhaseV

Cheryl Fitzer-Attas

Medical Director

Raviv Pryluk

Ceo And Co-Founder

Elad Berkman

Cto & Co-Founder

Brad Carlin

Senior Director

Yael Hadad